Press release from Companies: Resolutions of the Annual General Meeting 2024 of Curasight A/S

Press release from Companies: Curasight not to proceed with rights issue; evaluating alternative financing opportunities

Press release from Companies: Notice of Annual General Meeting 2024

Press release from Companies: The subscription period in Curasight’s rights issue begins today

Press release from Companies: Curasight publishes information memorandum in connection with forthcoming rights issue

Press release from Companies: Annual Report for the fiscal year 2023

Reports: Year-end report October – December 2023

Reports: Year-end report October – December 2023

Press release from Companies: Curasight resolves on a rights issue of up to DKK 51.2 million to accelerate its therapeutic strategy

Press release from Companies: Curasight announces acceleration of therapeutic strategy to strengthen position as a radiopharmaceutical theranostic company

Press release from Companies: Curasight A/S Achieves First Milestone under collaboration with Curium Inc.

Press release from Companies: Curasight A/S submits clinical trial application (CTA) for phase 2 trial with uTRACE[®] in prostate cancer patients